In prostate cancer EGF stimulates tumor progression via the coordinated ROS production, the phosphorylation of STAT3 (required for EGF-induced upregulation of HIF-1α) and the consequent induction of HIF-1α/Twist1/N-cadherin signaling pathway [114]. Here, TWIST1 is linked to prostate cancer.